| scholarly article | Q13442814 |
| P50 | author | Ian M Frayling | Q43208660 |
| P2093 | author name string | I M FRAYLING | |
| P2860 | cites work | The mutation rate and cancer | Q34410886 |
| Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in experimental animals | Q34636819 | ||
| Frequency of replication errors in colorectal cancer and their association with family history | Q35352538 | ||
| Genetic instability in colorectal cancer | Q35352665 | ||
| Microsatellite instability-a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer | Q35355631 | ||
| Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis | Q35355789 | ||
| Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences | Q35753544 | ||
| DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? | Q37229443 | ||
| Increased somatic recombination in methylation tolerant human cells with defective DNA mismatch repair | Q38338039 | ||
| Mlh1 is unique among mismatch repair proteins in its ability to promote crossing-over during meiosis | Q38344945 | ||
| BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. | Q40907031 | ||
| Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. | Q41148612 | ||
| Genomic instability and tolerance to alkylating agents. | Q41284271 | ||
| DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines | Q41338982 | ||
| Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer | Q41603127 | ||
| Clues to the pathogenesis of familial colorectal cancer | Q42622043 | ||
| Replication errors: cha(lle)nging the genome | Q42660015 | ||
| The genomic challenge | Q42760460 | ||
| Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites | Q48517465 | ||
| Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. | Q50893078 | ||
| Four letters in the genetic alphabet: a frozen evolutionary optimum? | Q52443838 | ||
| Inequality in mutation rates of the two strands of DNA. | Q52849056 | ||
| Incidence of DNA replication errors in patients with multiple primary cancers. | Q52867020 | ||
| DNA mismatch repair in lymphoblastoid cells from hereditary non-polyposis colorectal cancer (HNPCC) patients is normal under conditions of rapid cell division and increased mutational load. | Q52893411 | ||
| Microsatellite instability analysis: a multicenter study for reliability and quality control. | Q54225696 | ||
| Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog | Q57337207 | ||
| Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease | Q57567959 | ||
| Microsatellite instability in human colonic cancer is not a useful clinical indicator of familial colorectal cancer | Q71584350 | ||
| Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes | Q71733947 | ||
| Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients | Q72313890 | ||
| Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history | Q72657539 | ||
| Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome | Q72657543 | ||
| Microsatellite instability in colorectal adenomas | Q73309470 | ||
| Genetic instability in patients with metachronous colorectal cancers | Q73550497 | ||
| The value of microsatellite instability in the detection of HNPCC families and of sporadic colorectal cancers with special biological features: an investigation on a series of 100 consecutive cases | Q77467844 | ||
| Rapid and nonisotopic SSCP-based analysis of the BAT-26 mononucleotide repeat for identification of the replication error phenotype in human cancers | Q77477094 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microsatellite | Q265193 |
| P304 | page(s) | 1-4 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Microsatellite instability | |
| P478 | volume | 45 |
| Q35200499 | A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life. |
| Q38024260 | Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. |
| Q37434152 | Chronic pelvic pain in women: etiology, pathogenesis and diagnostic approach. |
| Q34786704 | Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome |
| Q36058471 | Colorectal cancer screening: prospects for molecular stool analysis |
| Q36649118 | CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection. |
| Q33852241 | Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome |
| Q36122008 | Effects of anti-secretory factor (ASF) on irritable bowel syndrome (IBS). A double-blind, randomized study |
| Q54577914 | Enhanced detection of microsatellite instability and mismatch repair gene expression in cutaneous squamous cell carcinomas. |
| Q53405846 | Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis. |
| Q57737908 | Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer |
| Q51853763 | Incorporating genotype uncertainty into mark-recapture-type models for estimating abundance using DNA samples. |
| Q90101614 | Intestinal gases: influence on gut disorders and the role of dietary manipulations |
| Q43782357 | Irritable bowel syndrome: new horizons in pathophysiology and treatment |
| Q39756148 | Low social class is linked to upper gastrointestinal symptoms in an Australian sample of urban adults |
| Q73276320 | Management of irritable bowel syndrome |
| Q34598419 | Methods of molecular analysis: mutation detection in solid tumours |
| Q34217505 | Microsatellite instability: application in hereditary non-polyposis colorectal cancer. |
| Q35200808 | Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease |
| Q73594059 | Optimising methods for determining RER status in colorectal cancers |
| Q34975960 | Pathogenesis and clinical management of hereditary non-polyposis colorectal cancer |
| Q41535002 | Prevalence of esophageal eosinophilia and eosinophilic esophagitis in adults: a population-based endoscopic study in Shanghai, China |
| Q34533276 | The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome |
| Q36407290 | The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome. |
Search more.